Mesoblast (MEOBF) Total Liabilities (2017 - 2025)

Mesoblast (MEOBF) has disclosed Total Liabilities for 9 consecutive years, with $187.2 million as the latest value for Q2 2025.

  • Quarterly Total Liabilities fell 0.82% to $187.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $187.2 million through Jun 2025, down 0.82% year-over-year, with the annual reading at $187.2 million for FY2025, 0.82% down from the prior year.
  • Total Liabilities hit $187.2 million in Q2 2025 for Mesoblast, down from $188.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $188.8 million in Q2 2024 to a low of $163.3 million in Q2 2021.
  • Historically, Total Liabilities has averaged $174.4 million across 5 years, with a median of $167.6 million in 2023.
  • Biggest five-year swings in Total Liabilities: decreased 11.37% in 2021 and later grew 12.66% in 2024.
  • Year by year, Total Liabilities stood at $163.3 million in 2021, then increased by 1.09% to $165.1 million in 2022, then increased by 1.5% to $167.6 million in 2023, then grew by 12.66% to $188.8 million in 2024, then decreased by 0.82% to $187.2 million in 2025.
  • Business Quant data shows Total Liabilities for MEOBF at $187.2 million in Q2 2025, $188.8 million in Q2 2024, and $167.6 million in Q2 2023.